Aspire Biopharma Holdings, Inc. (ASBP) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | -$6.38M | -314.0% |
| 2024 | -$1.54M | -215.7% |
| 2023 | -$487.9K | +95.1% |
| 2022 | -$9.94M | -2092089.7% |
| 2021 | -$475 | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | -$6.38M | -314.0% |
| 2024 | -$1.54M | -215.7% |
| 2023 | -$487.9K | +95.1% |
| 2022 | -$9.94M | -2092089.7% |
| 2021 | -$475 | — |